Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History OPTN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics OPTN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

OptiNose

OPTN
Current price
9.60 USD 0 USD (0.00%)
Last closed 9.60 USD
ISIN US68404V1008
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 97 223 040 USD
Yield for 12 month -49.61 %
1Y
3Y
5Y
10Y
15Y
OPTN
21.11.2021 - 28.11.2021

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. It offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase III clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania. As of May 21, 2025, OptiNose, Inc. operates as a subsidiary of Paratek Pharmaceuticals, Inc. Address: 777 Township Line Road, Yardley, PA, United States, 19067

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

21.00 USD

P/E Ratio

Dividend Yield

Financials OPTN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures OPTN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+78 226 000 USD

Last Year

+70 987 000 USD

Current Quarter

+18 510 000 USD

Last Quarter

+22 419 000 USD

Current Year

+70 995 000 USD

Last Year

+62 354 000 USD

Current Quarter

+16 760 000 USD

Last Quarter

+20 465 000 USD
EBITDA -15 570 000 USD
Operating Margin TTM -41.01 %
Price to Earnings
Return On Assets TTM -9.97 %
PEG Ratio
Return On Equity TTM -1 050.50 %
Wall Street Target Price 21.00 USD
Revenue TTM 81 856 000 USD
Book Value -6.06 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 24.40 %
Dividend Yield
Gross Profit TTM 74 106 000 USD
Earnings per share -2.17 USD
Diluted Eps TTM -2.17 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -36.52 %

Stock Valuation OPTN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.87
Price Sales TTM 1.19
Enterprise Value EBITDA -4.33
Price Book MRQ 24.26

Technical Indicators OPTN

For 52 Weeks

4.82 USD 19.50 USD
50 Day MA 8.91 USD
Shares Short Prior Month 142 207
200 Day MA 8.83 USD
Short Ratio 1.38
Shares Short 132 651
Short Percent 1.51 %